HemaSphere (Aug 2023)

S212: A RANDOMIZED DOUBLE-BLIND PHASE 3 STUDY OF JAKTINIB VERSUS HYDROXYUREA IN PATIENTS WITH INTERMEDIATE-2 OR HIGH RISK MYELOFIBROSIS

  • Yi Zhang,
  • Hu Zhou,
  • Junling Zhuang,
  • Aili He,
  • Yarong LI,
  • Linhua Yang,
  • Xin Du,
  • Sujun Gao,
  • Guangsheng He,
  • Mei Hong,
  • Qian Jiang,
  • Zhongxing Jiang,
  • Sun Kai,
  • Lingling Yue,
  • Cuiping Zheng,
  • Zeping Zhou,
  • Chenghao Jin,
  • Hongmei Jing,
  • Lin Liu,
  • Qingchi Liu,
  • Jishi Wang,
  • Wen Wu,
  • Yajing Xu,
  • Dengshu Wu,
  • Na Xu,
  • Feng Zhang,
  • Jin Zhang,
  • Huanling Zhu,
  • Zhijian Xiao,
  • Jie Jin

DOI
https://doi.org/10.1097/01.HS9.0000967760.70775.53
Journal volume & issue
Vol. 7
p. e7077553

Abstract

Read online

No abstracts available.